Page 1 of Clinical Trials for Risperdal Consta, 497 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
High Dose Risperidone Consta for Patients With Schizophrenia With Poor Response to Risperidone
Last Updated: November 1, 2010
Condition(s): Schizophrenia; Schizoaffective Disorder
2
Recruiting
Oral Versus Injectable Risperidone for Treating First-Episode Schizophrenia
Last Updated: October 11, 2011
Condition(s): Schizophrenia
3
Completed
Risperdal Consta for Bipolar Disorder
Last Updated: February 4, 2011
Condition(s): Bipolar I Disorder
4
Completed
Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder
Last Updated: October 19, 2011
Condition(s): Schizophrenia; Psychotic Disorders; Substance Abuse; Alcohol Abuse
5
Completed
A 4-Week Study of Mifepristone in the Prevention of Risperidone-Induced Weight Gain in Healthy Male Volunteers
Last Updated: February 2, 2009
Condition(s): Healthy
6
Completed
Evaluation of the Usefulness to Doctors of the Risperdal Consta Treatment Guidebook Over a Three-month Period During Which Adult Patients With Schizophrenia or Schizoaffective Disorder Are Switching From Daily Doses or Risperidone Tablets to Long-acting Risperidone by Injection
Last Updated: May 17, 2011
Condition(s): Schizophrenia; Psychotic Disorders
7
Completed
RiSPECT: Risperdal Safety Protocol Evaluation Consta Treatment, a Post Authorization Safety Survey to Obtain Information on the Safety and Efficacy of Risperidone When Used in Routine Clinical Practice
Last Updated: October 15, 2010
Condition(s): Schizophrenia; Psychotic Disorders; Schizoaffective Disorder
8
Completed
Long-acting Injectable Risperidone in Patients With Schizophrenia After an Acute Episode
Last Updated: October 25, 2011
Condition(s): Schizophrenia
9
Completed
A Study to Evaluate Social Functioning of Long Acting Injectable Risperidone and Oral Risperidone in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder
Last Updated: December 9, 2011
Condition(s): Schizophrenia; Psychotic Disorders
10
Completed
Effect of Add-on Citalopram to Risperidone on Negative Symptoms in Schizophrenia
Last Updated: May 4, 2009
Condition(s): Schizophrenia; Negative Symptoms
11
Completed
Bioavailability Study of Risperidone Orally Disintegrating Tablets 1 mg of Dr.Reddy's Laboratories Limited Under Fasting Conditions
Last Updated: July 1, 2010
Condition(s): Healthy
12
Completed
Bioavailability Study of Risperidone Orally Disintegrating Tablets 1 mg of Dr.Reddy's Laboratories Limited Under Fed Conditions
Last Updated: July 1, 2010
Condition(s): Healthy
13
Completed
A Study to Evaluate Treatment Adherence in Schizophrenia With Long Acting Risperidone Microspheres (e-STAR)
Last Updated: June 23, 2011
Condition(s): Schizophrenia; Tranquilizing Agents; Mental Disorders; Therapeutic Uses; Physiological Effects of Drugs; Psychotropic Drugs; Antipsychotic Agents
14
Recruiting
Safety and Efficacy of Zicronapine in Patients With Schizophrenia
Last Updated: October 14, 2011
Condition(s): Schizophrenia
15
Completed
A Study of the Effectiveness and Safety of Long Acting Risperidone in Patients With Schizophrenia or Schizoaffective Disorders Who Are Receiving Psychiatric Home Care Treatment
Last Updated: April 26, 2010
Condition(s): Risperdal Consta; Schizophrenia; Schizoaffective Disorders
16
Completed
Characterization of Intramuscular Injections of Risperidone 4 Week Long-acting Injectable (LAI) Formulation in the Buttock of Patients With Schizophrenia
Last Updated: May 17, 2011
Condition(s): Psychotic Disorders; Schizophrenia
17
Active, not recruiting
A Double-blind, Placebo Controlled Trial of Risperidone for the Treatment of Anorexia Nervosa
Last Updated: May 27, 2011
Condition(s): Anorexia Nervosa
18
Recruiting
Risperidone and Desipramine in Alcohol Use and Schizophrenia
Last Updated: December 9, 2011
Condition(s): Schizophrenia; Alcoholism; Dual Diagnosis
19
Completed
Risperidone 1 mg Tablet in Healthy Subjects Under Fasting Conditions
Last Updated: January 26, 2009
Condition(s): Healthy
20
Completed
A Study of How Long it Takes a Patient to Relapse After Switching From an Oral Antipsychotic to One of Two Doses of Long-acting Risperidone Injections in Patients With Schizophrenia or Schizoaffective Disorder
Last Updated: May 17, 2011
Condition(s): Schizophrenia; Schizoaffective Disorder

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://www.clinicaltrialsfeeds.org/clinical-trials/results/?term=Risperdal+Consta

Page 1 of Clinical Trials for Risperdal Consta, 497 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About